CYP2C9 Gene Coumarin/Warfarin Resistance Due to CYP2C9 Variants NGS Genetic DNA Test
Introduction to the Test
The CYP2C9 Gene Coumarin/Warfarin Resistance Due to CYP2C9 Variants NGS Genetic DNA Test is a vital diagnostic tool that helps identify genetic variations affecting how individuals metabolize warfarin, a commonly prescribed anticoagulant. Understanding these genetic factors is crucial for optimizing treatment plans, minimizing the risk of adverse drug reactions, and ensuring effective anticoagulation therapy.
What the Test Measures
This test specifically detects variants in the CYP2C9 gene, which encodes an enzyme responsible for metabolizing warfarin. By analyzing these genetic variants, healthcare providers can predict a patient’s sensitivity to warfarin, guiding dosage adjustments and improving therapeutic outcomes.
Who Should Consider This Test
Individuals who are prescribed warfarin or other anticoagulants should consider this test, especially if they have:
- A family history of adverse reactions to warfarin
- Unexplained variations in warfarin response
- Conditions that may affect drug metabolism
- Symptoms of bleeding or clotting disorders
Benefits of Taking the Test
Taking the CYP2C9 Gene Coumarin/Warfarin Resistance Test offers several benefits:
- Personalized medication management based on genetic profile
- Reduced risk of complications from incorrect dosing
- Improved therapeutic outcomes and patient safety
- Informed decision-making regarding anticoagulant therapy
Understanding Your Results
Results from the CYP2C9 Gene Coumarin/Warfarin Resistance Test will indicate whether you possess any variants that may affect warfarin metabolism. Generally, patients with certain variants may require lower doses of warfarin to achieve the desired anticoagulant effect. It is essential to discuss your results with your healthcare provider for appropriate action and management.
Test Pricing
| Discount Price | Regular Price |
|---|---|
| 400,000 NGN | 560,000 NGN |
Booking the Test
To ensure safe and effective treatment, consider booking the CYP2C9 Gene Coumarin/Warfarin Resistance Test today. For appointments or inquiries, please contact us at +2348077798758 or visit our website to book online.
Additional Information
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One Drop of Blood on FTA Card
Pre-test Instructions: A genetic counseling session is recommended to draw a pedigree chart of family members affected by Coumarin/Warfarin resistance due to CYP2C9 variants.
Specialty: General Physician
Department: Genetics
Method: NGS Technology
Disease Type: Metabolic Disorders
